Quantcast

Latest Novartis Stories

2014-06-04 08:34:06

LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Hepatitis Drugs and Vaccines: World Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/therapeutic/hepatitis_drugs_vaccines_world_market_2013_2023.html Report DetailsYour guide to sales outlooks and R&D for hepatitis treatmentsWhere are hepatitis medicines going? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and...

2014-06-03 12:31:25

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:World OTC Pharmaceutical Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/world_otc_pharmaceutical_market_2012_2022.html Report DetailsDiscover the highest potential revenues in over-the-counter medicineWhat does the future hold for OTC medicines? Visiongain's report shows you potential revenues to 2023, assessing data, trends, opportunities and...

2014-06-02 12:29:47

Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Advancing BOULDER, Colo., June 2, 2014 /PRNewswire/ -- Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and selumetinib, were showcased at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). At the meeting, preliminary data for the combination of binimetinib and CDK4/6 inhibitor LEE011 (discovered by Novartis Institutes for BioMedical Research in collaboration with Astex...

2014-06-02 08:32:06

Results show adding LBH589 to bortezomib and dexamethasone significantly improved PFS by 37%, meeting Phase III study primary endpoint1 EAST HANOVER, N.J., June 2, 2014 /PRNewswire/ -- Novartis today presented results from a pivotal Phase III trial showing a 37% improvement in progression-free survival (PFS) when using the investigational compound LBH589 (panobinostat) in combination with bortezomib[*] and dexamethasone compared to treatment with the same regimen with placebo in patients with...

2014-05-27 23:04:17

AgFunder, an online investment crowdfunding platform for agriculture and agtech opportunities, is hosting a webinar for accredited investors interested in aWhere, a cloud-based service delivering hyperlocal weather data and recommendations to farmers around the globe. New York, NY (PRWEB) May 27, 2014 aWhere will be raising a $4 million equity financing round on the investment crowdfunding platform AgFunder. aWhere is a Colorado-based agtech company delivering hyperlocal weather data and...

2014-05-27 12:23:12

- Contest runs through July for innovative ideas to support the six commitments of The Good Growth Plan WASHINGTON, May 27, 2014 /PRNewswire/ -- Syngenta announced today a contest for creative ideas that will support one or more of the six measurable commitments of The Good Growth Plan. The Good Growth Plan Grant Contest* will award one Grand Prize of $20,000 to help the winner implement the idea. Also, three runners-up will receive $10,000 each for the same purpose. Deadline for submissions...

2014-05-19 16:24:18

Appoints Nicholas A. Saccomano, Ph.D. as Chief Scientific Officer and Robert E. Winkler, M.D. as Vice President of Clinical Development BOULDER, Colo., May 19, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointments of Nicholas A. Saccomano, Ph.D., as Chief Scientific Officer and Robert E....

2014-05-19 08:28:56

DUBLIN, May 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rd8s6p/meningococcal) has announced the addition of the "Global Meningococcal Vaccines Market - Forecasts to 2019: Sanofi, Novartis, GlaxoSmithKline, Pfizer, Serum Institute of India, JN-International, Nuron, Baxter and Biomed" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Meningococcal disease caused by the bacterium Neisseria meningitidis is a life...

2014-05-15 12:35:20

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ophthalmic Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/treatments/eye_care/ophthalmic_drugs_world_market_prospects.html Report DetailsHow to find trends and revenue predictions for the ophthalmic drug industryWhat are the commercial prospects for treating eye disorders? Visiongain's new report gives you forecasted revenues to 2023. It explains trends,...

2014-05-15 12:34:27

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibacterial Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/generic_drugs/antibacterial_drugs_world_market_prospects.html Report DetailsDiscover new trends, opportunities and revenue prospects for bacteria-killing medicinesWhere's the antibiotics market heading? How are those products performing? Visiongain's updated report gives you forecasted revenues...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'